These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 749836)

  • 1. Combined therapy of mice bearing L1210 leukemia with adriamycin and mycobacteria.
    Fiszer L; Mordarski M
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):873-9. PubMed ID: 749836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of combined treatment of L1210 leukemia with adriamycin and pustulan.
    Fiszer-Maliszewska L; Mordarski M
    Arch Immunol Ther Exp (Warsz); 1981; 29(6):703-10. PubMed ID: 7349092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoimmunotherapy of L1210 leukemia with adriamycin, cyclophosphamide, and OK-432, and their effects on the generation of antitumor immunity.
    Ujiie T
    Jpn J Cancer Res; 1987 Jul; 78(7):737-47. PubMed ID: 3114200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of alpha-difluoromethylornithine alone and combined with adriamycin or vindesine on L1210 leukemia in mice, EMT6 solid tumors in mice, and solid tumors induced by injection of hepatoma tissue culture cells in rats.
    Bartholeyns J; Koch-Weser J
    Cancer Res; 1981 Dec; 41(12 Pt 1):5158-61. PubMed ID: 6796266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adriamycin and cyclophosphamide in combination chemotherapy of L1210 leukemia.
    Avery TL; Roberts D
    Cancer Res; 1977 Mar; 37(3):678-83. PubMed ID: 837368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of N-trifuloroacetyladriamycin-14-valerate.
    Pratesi G; Casazza AM; Di Marco A
    Cancer Treat Rep; 1978 Jan; 62(1):105-10. PubMed ID: 626988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antileukemic effects of recombinant human tumor necrosis factor alpha (rh-TNF alpha) with cyclophosphamide or methotrexate on leukemia L1210 and leukemia P388 in mice.
    Warzocha K; Robak T
    Acta Haematol Pol; 1992; 23(1):55-62. PubMed ID: 1615753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined effect of lipoic acid and doxorubicin in murine leukemia.
    Dovinová I; Novotný L; Rauko P; Kvasnicka P
    Neoplasma; 1999; 46(4):237-41. PubMed ID: 10613604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of actinomycin D or adriamycin antitumor activity with DNA.
    Marks TA; Venditti JM
    Cancer Res; 1976 Feb; 36(2 Pt 1):496-504. PubMed ID: 1260747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre- and co-treatment with xanthophyll enhances the anti-leukemic activity of adriamycin.
    Lee KH
    J Photochem Photobiol B; 2008 Sep; 92(3):175-9. PubMed ID: 18653355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone does not enhance antileukemic activity of cladribine in mice with leukemias L1210 and P388.
    Robak T; Szmigielska A
    Neoplasma; 2000; 47(3):168-71. PubMed ID: 11043840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antitumor effect of methylene blue in vivo].
    Lai BT
    Zhonghua Zhong Liu Za Zhi; 1989 Mar; 11(2):98-100. PubMed ID: 2806052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined effects of immunity and antitumor drugs against cancer. I. In vivo studies with cis-diamminedichloroplatinum and cyclophosphamide in mouse models.
    Ricci F; De Filippi R; Riccardi C; Romani L; Giuliani A
    Chemioterapia; 1987 Dec; 6(6):403-9. PubMed ID: 3435922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of vitamin E on toxicity and antitumor activity of adriamycin in mice.
    Tanigawa N; Katoh H; Kan N; Mizuno Y; Tanimura H; Satomura K; Hikasa Y
    Jpn J Cancer Res; 1986 Dec; 77(12):1249-55. PubMed ID: 3102429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy and immunotherapy of L1210 leukemic mice with antigenic tumor sublines.
    Nicolin A; Canti G; Marelli O; Veronese F; Goldin A
    Cancer Res; 1981 Apr; 41(4):1358-62. PubMed ID: 7011535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy-increased antineoplastic effects of antibody-toxin conjugates.
    Sironi M; Canegrati MA; Romano M; Vecchi A; Spreafico F
    Cancer Treat Rep; 1984 Apr; 68(4):643-5. PubMed ID: 6713420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of levamisole administration on treatment with 6-mercaptopurine riboside of mice bearing L1210 leukemia cells.
    Miura T; Nogiwa E; Kurashige S; Maekawa T
    Cancer Res; 1980 Dec; 40(12):4813-6. PubMed ID: 7438114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 6-Mercaptopurine-induced potentiation of active immunotherapy in L1210-bearing mice treated with concanavalin A-bound leukemia cell vaccine.
    Kataoka T; Akahori Y; Sakurai Y
    Cancer Res; 1984 Feb; 44(2):519-24. PubMed ID: 6537896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective chemo-immunotherapy of L1210 leukemia in vivo using interleukin-12 combined with doxorubicin but not with cyclophosphamide, paclitaxel or cisplatin.
    Zagozdzon R; Gołab J; Stokłosa T; Giermasz A; Nowicka D; Feleszko W; Lasek W; Jakóbisiak M
    Int J Cancer; 1998 Aug; 77(5):720-7. PubMed ID: 9688305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell kill kinetics of several nogalamycin analogs and adriamycin for Chinese hamster ovary, L1210 leukemia, and B16 melanoma cells in culture.
    Bhuyan BK; Blowers CL; Crampton SL; Shugars KD
    Cancer Res; 1981 Jan; 41(1):18-24. PubMed ID: 7448758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.